The pharma industry is vital in healthcare, contributing significantly to medical advancements and improved patient outcomes. However, the pricing strategies employed by pharmaceutical companies have become a topic of intense scrutiny and debate. The gap between the cost of producing drugs and their market prices has raised questions about the ethics and sustainability of the current pricing model.